Athira Pharma Inc (ATHA): Narxning sotuvga nisbati
Athira Pharma, Inc. (ATHA) terapiyasining muvaffaqiyati oqsillarni tashish paytida harorat nazoratiga qat'iy rioya qilinishiga bog'liq. Fosgonimeton uchun patentlar va FDA ning qat'iy nazorati kirish uchun yuqori to'siqlarni yaratadi. Kutilayotgan kichik molekulyar testlar yangi o'sish triggerlari vazifasini o'taydi. P/S koeffitsiyentining o'zgarishi bozor baholashini aks ettiradi, bunda ko'rsatkich hozirda darajasida.
%20P%2FS%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_ATHA_-_Athira-Pharma-Inc._-_PS-Multiple "ATHA - Athira Pharma Corp Bozor kapitallashuvining daromadga nisbati 04.07.2022 - 14.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Athira (ATHA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Athira Pharma, Inc.|ATHA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Athira Pharma Corp|ATHA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Athira|ATHA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Athira Pharma|Oraliq qoplama koeffitsiyenti athira.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ATHA - Kompaniyaning sof foydasi|Sof foyda prognozi Athira Pharma, Inc.|ATHA - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Athira Pharma Inc|ATHA - Narx-foyda va o‘sish multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Athira|ATHA - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Athira Pharma|ATHA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati athira.com|ATHA - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Athira Pharma, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:ATHA athira.com
Yuqori sifatli aktivlarni tanlash uchun investor biznesning bozor qiymatini uning daromad keltirishga bo'lgan haqiqiy qobiliyati bilan solishtirishi kerak. P/S koeffitsiyenti bozor kapitalizatsiyasining yillik daromadga nisbati sifatida hisoblanadi va bu savdoning har bir dollari uchun bozorning bahosini belgilaydi. Athira Pharma, Inc. (ATHA) uchun ushbu metrika Altsgeymer kasalligi davolash vositalarining tijoratlashtirilishiga oid kutishlarni aks ettiradi. Kapitalizatsiyaning daromadga nisbatini tahlil qilish orqali aksiyaning joriy pul oqimlariga nisbatan qanchalik hadda haddan tashqari sotib olinganligini baholash mumkin.
Athira Pharma, Inc. kimlar bilan raqobatlashadi
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC (Regencell Bioscience Ltd) - Narxning sotuvga nisbati|Axsome Therapeutics Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|XENE: P/S multiplikatori|vikingtherapeutics.com (VKTX) - P/S multiplikatori|Narxning daromadga nisbati Supernus|CPRX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|Kapitalizatsiyaning daromadga nisbati Harmony Corp HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|P/S multiplikatori amylyx.com AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRAX (Praxis Precision Medicines Inc)|AVXL: P/S multiplikatori|CBLL - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Prothena Biosciences|Kapitalizatsiya va daromad nisbati ALEC (Alector Therapeutics)|P/S multiplikatori ANNX|Kapitalizatsiyaning daromadga nisbati omeros.com OMER|Neurogene Corp - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti AC Immune Inc (ACIU)|Voyager Therapeutics - P/S multiplikatori|NMRA - P/S multiplikatori|SCLX (Scilex) - Kapitalizatsiyaning daromadga nisbati|TVGN: Kapitalizatsiyaning sotish hajmiga nisbati|ACOG (Alpha Cognition Inc) - P/S multiplikatori|CGTX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori IKT|P/S multiplikatori cassavasciences.com (SAVA)|Narxning daromadga nisbati Assertio ASRT|COYA: Kapitalizatsiya va daromad nisbati|VistaGen Therapeutics Inc - P/S multiplikatori|Sotuvga nisbatan narx Ovid Therapeutics Inc.|ABOS (Acumen Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|cervomed.com (CRVO) - P/S multiplikatori|Narxning daromadga nisbati Alterity Therapeutics Ltd.|CLNN: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati PepGen Inc. (PEPG)|JUNS - Sotuvga nisbatan narx|P/S multiplikatori RLMD (Relmada Therapeutics)|P/S multiplikatori annovisbio.com ANVS|GRCE: Kapitalizatsiyaning daromadga nisbati|Firefly Neuroscience, Inc. - Kapitalizatsiyaning sotish hajmiga nisbati|KLTO: P/S multiplikatori|NeuroSense Therapeutics Ltd. - Bozor kapitallashuvining daromadga nisbati|RVPH (Reviva Pharmaceuticals) - P/S multiplikatori|MetaVia, Inc. (MTVA) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati NeurAxis (NRXS)|HSDT (heliusmedical.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori PASG (Passage Bio)|P/S multiplikatori Neuphoria Therapeutics, Inc. NEUP|NERV: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ADXN (addextherapeutics.com)|alzamend.com (ALZN) - Narxning daromadga nisbati|Narxning sotuvga nisbati CYCN (Cyclerion Therapeutics, Inc.)|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|KTTA: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CRGT|P/S multiplikatori avenuetx.com (ATXI)|Narxning daromadga nisbati BrainStorm Cell Therapeutics BCLI|Bozor kapitallashuvining daromadga nisbati CARA|CHRO - Narxning daromadga nisbati|Eliem Therapeutics (ELYM) - Kapitalizatsiyaning daromadga nisbati|ITCI: P/S multiplikatori|longboardpharma.com (LBPH) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati MRNS|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|Narx/daromad koeffitsiyenti Sage Therapeutics Inc|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN: Kapitalizatsiya va daromad nisbati|Vigil Neuro - P/S multiplikatori|anewmeds.com (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel) - Kapitalizatsiyaning daromadga nisbati
